A Multicenter Phase 2 Study of Ultrahypofractionated Stereotactic Boost After External Beam Radiotherapy in Intermediate-risk Prostate Carcinoma: A Very Long-term Analysis of the CKNO-PRO Trial

A Multicenter Phase 2 Study of Ultrahypofractionated Stereotactic Boost After External Beam Radiotherapy in Intermediate-risk Prostate Carcinoma: A Very Long-term Analysis of the CKNO-PRO Trial

Background: Genitourinary (GU) or gastrointestinal (GI) complications and tumor relapse can occur in the long term after radiotherapy for prostate cancer. Objective: To assess the late tolerance and relapse-free survival (RFS) in patients undergoing hypofractionated stereotactic boost therapy after...

Full description

Bibliographic Details
Main Authors: David Pasquier, Philippe Nickers, Didier Peiffert, Philippe Maingon, Pascal Pommier, Thomas Lacornerie, Emmanuelle Tresch, Maël Barthoulot, Eric Lartigau
Format: Article
Language:English
Published: Elsevier 2023-08-01
Series:European Urology Open Science
Subjects:
Intermediate-risk prostate cancer
Prostate cancer
Stereotactic body radiotherapy
Stereotactic body radiotherapy boost
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168323003567

Internet

http://www.sciencedirect.com/science/article/pii/S2666168323003567

Similar Items